Stocks to Watch: Pfizer, Moderna, Lululemon Athletica
14 10월 2023 - 9:17AM
Dow Jones News
By Ben Glickman
Pfizer said it would reverse $4.2 billion in revenue after
revising its agreement with the U.S. government related to its
Covid-19 treatment Paxlovid. The company agreed to take back unused
courses for the oral anti-viral pill as it seeks to roll out its
commercial version of the drug. Shares fall 3.1% to $31.10
after-hours.
Moderna, which produces Covid-19 vaccines, saw its shares slump
after Pfizer warned of lower-than-expected demand for Covid-19
vaccines and treatments. Pfizer slashed its expectations for
revenue and adjusted earnings after the market closed on Friday as
its Covid-related products saw lagging sales, a warning sign for
the results of other vaccine makers. Moderna shares fall 4% to
$94.40 after-hours.
Lululemon Athletica's stock will join the S&P 500 effective
Oct. 18. The excercise apparel company will replace Activision
Blizzard, which was acquired by Microsoft on Friday. Shares rise
4.9% to $396.13 after-hours.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
October 13, 2023 20:02 ET (00:02 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Lululemon Athletica (NASDAQ:LULU)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Lululemon Athletica (NASDAQ:LULU)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
